Neuren Pharmaceuticals | NEU - Assets



Neuren Pharmaceuticals reported AUD409.71M in Assets for its fiscal semester ending in December of 2024.


Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Avita Medical AUD 79.71M 8.12M Dec/2024
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Genetic Signatures AUD 59.01M 8.27M Dec/2024
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
Medical Developments International AUD 65.33M 6.17M Dec/2024
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Organon & Co USD 13.5B 344M Jun/2025
Paradigm Biopharmaceuticals AUD 35.36M 7.97M Dec/2024
PYC Therapeutics AUD 68.23M 23.01M Dec/2024
Starpharma Holdings AUD 29.62M 7.2M Dec/2024
Tectonic Therapeutic USD 295.31M 142.4M Jun/2025
Telix Pharmaceuticals AUD 1.52B 770.47M Dec/2024
Viatris USD 38.41B 63.4M Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025